SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 weight (est.): 1.85% · F&O lot size: 350SUNPHARMA lot size: 350 shares per F&O lot for the 3 listed expiries (2026-10-27, 2026-11-23, 2026-12-29). One lot is worth about ₹6.10 lakh at the last underlying price of ₹1,743.01. All F&O lot sizes →
SUNPHARMA Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
SUNPHARMA Seasonality month by month since 1996 · adjusted month-end closes
SUNPHARMA in October: closed the month higher in 15 of 30 years (1996–2025), with a median move of -0.1% and an average of +0.8%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about SUNPHARMA
In the last completed session, Sun Pharmaceutical Industries Ltd. closed -0.88% with futures open interest moving -0.0%. Positioning is neutral — neither side is decisively adding or unwinding right now. The option PCR of 0.75 is balanced — no clear directional preference from option writers. Max-pain strike at ₹1,780 sits 2.1% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. is best read as range-bound for now.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-06-24 | BUY | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794 |
| 2026-06-24 | SELL | ₹ 1,868.00 | 28.85 | THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 |
Insider & Promoter Filings last 60 days
SUNPHARMA Option Chain nearest expiry 2026-10-27 · spot 1,743 · EOD 2026-10-19
SUNPHARMA option chain today (2026-10-27 expiry, NSE data of 2026-10-19): put-call ratio 0.75 · max pain ₹1,780 · highest call OI at ₹1,760 · highest put OI at ₹1,780 · underlying ₹1,743.01. One lot is 350 shares. At-the-money implied volatility 16.9%, IV rank 21 and IV percentile 47 over the past year (range 13.0%–31.2%); 20-day historical volatility 16.9%.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 48%
Δ 0.98
θ -0.6
ν 0
|
1520 |
IV 48%
Δ -0.02
θ -0.3
ν 0
|
|
IV 40%
Δ 0.98
θ -0.6
ν 0
|
1560 |
IV 40%
Δ -0.02
θ -0.3
ν 0
|
|
IV 38%
Δ 0.97
θ -0.7
ν 0
|
1580 |
IV 38%
Δ -0.03
θ -0.4
ν 0
|
|
IV 30%
Δ 0.98
θ -0.5
ν 0
|
1600 |
IV 30%
Δ -0.02
θ -0.2
ν 0
|
|
IV 26%
Δ 0.98
θ -0.5
ν 0
|
1620 |
IV 26%
Δ -0.02
θ -0.2
ν 0
|
|
IV 23%
Δ 0.97
θ -0.5
ν 0
|
1640 |
IV 23%
Δ -0.03
θ -0.2
ν 0
|
|
IV 22%
Δ 0.95
θ -0.7
ν 0
|
1660 |
IV 22%
Δ -0.05
θ -0.4
ν 0
|
|
IV 20%
Δ 0.91
θ -0.8
ν 0
|
1680 |
IV 20%
Δ -0.09
θ -0.5
ν 0
|
|
IV 19%
Δ 0.83
θ -1.1
ν 1
|
1700 |
IV 19%
Δ -0.17
θ -0.8
ν 1
|
|
IV 18%
Δ 0.71
θ -1.3
ν 1
|
1720 |
IV 18%
Δ -0.29
θ -1.0
ν 1
|
|
IV 18%
Δ 0.54
θ -1.4
ν 1
|
1740 |
IV 18%
Δ -0.46
θ -1.1
ν 1
|
|
IV 18%
Δ 0.36
θ -1.3
ν 1
|
1760 R |
IV 18%
Δ -0.64
θ -1.0
ν 1
|
|
IV 19%
Δ 0.22
θ -1.0
ν 1
|
1780 S MP |
IV 19%
Δ -0.78
θ -0.7
ν 1
|
|
IV 20%
Δ 0.13
θ -0.8
ν 1
|
1800 |
IV 20%
Δ -0.87
θ -0.5
ν 1
|
|
IV 22%
Δ 0.08
θ -0.6
ν 0
|
1820 |
IV 22%
Δ -0.92
θ -0.3
ν 0
|
|
IV 24%
Δ 0.05
θ -0.5
ν 0
|
1840 |
IV 24%
Δ -0.95
θ -0.1
ν 0
|
|
IV 26%
Δ 0.04
θ -0.3
ν 0
|
1860 |
IV 26%
Δ -0.96
θ -0.0
ν 0
|
|
IV 27%
Δ 0.02
θ -0.3
ν 0
|
1880 |
IV 27%
Δ -0.98
θ +0.1
ν 0
|
|
IV 29%
Δ 0.02
θ -0.2
ν 0
|
1900 |
IV 29%
Δ -0.98
θ +0.1
ν 0
|
|
IV 31%
Δ 0.01
θ -0.2
ν 0
|
1920 |
IV 31%
Δ -0.99
θ +0.2
ν 0
|
|
IV 33%
Δ 0.01
θ -0.1
ν 0
|
1940 |
IV 33%
Δ -0.99
θ +0.2
ν 0
|
Chain Interpretation
Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
SUNPHARMA — frequently asked questions
What is the Sun Pharmaceutical Industries Ltd. share price today?
SUNPHARMA is trading at ₹1,743.00 (+0.00% vs previous close), per the latest update on this page.
What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 34.6.
What is the market cap of Sun Pharmaceutical Industries Ltd.?
SUNPHARMA has a market capitalisation of approximately ₹418,204 crore.
Is SUNPHARMA near its 52-week high?
SUNPHARMA is trading -14.8% from its 52-week high of ₹2,046.90 as of 2026-10-19.
What is the RSI of SUNPHARMA?
The 14-day RSI of SUNPHARMA is 34.4, which is considered neutral.
Is SUNPHARMA above its 200-day moving average?
SUNPHARMA is trading below its 200-DMA of ₹1,810.81 (-3.7% away).
What is the F&O buildup in SUNPHARMA?
The latest end-of-day derivatives data classifies SUNPHARMA as Neutral (bias: neutral), based on the day's combined price and open-interest change.
What is the max pain and PCR for SUNPHARMA options?
SUNPHARMA's option-chain max pain strike is ₹1,780 and its put-call ratio (OI) is 0.75, from the latest end-of-day option chain.
Are FIIs or big investors buying SUNPHARMA?
Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.